Sanofi v. Watson Labs., No. 2016-2726, 2017 (Fed. Cir. Nov. 9, 2017) (Before Prost, C.J., Wallach, and Taranto, J.) (Opinion for the court, Taranto, J.) Sanofi is the owner of two patents claiming compositions and uses of the cardiovascular drug dronedarone. The ‘167 patent claims methods of reduc
Sanofi v. Watson Labs., No. 2016-2726, 2017 (Fed. Cir. Nov. 9, 2017) (Before Prost, C.J., Wallach, and Taranto, J.) (Opinion for the court, Taranto, J.) Sanofi is the owner of two patents claiming compositions and uses of the cardiovascular drug dronedarone. The ‘167 patent claims methods of reduc
このブックマークにはスターがありません。
最初のスターをつけてみよう！
Specific Intent to Induce Patent Infringement Inferred from Pharmaceutical Label - IPWatchdog.com | Patents & Intellectual Property Law
1 人がブックマーク・1 件のコメント
＼ コメントが サクサク読める アプリです ／